Eloxatin
Links shared publicly online about this topic
Teva Settles Generic Eloxatin Litigation
medicalnewstoday.com — “Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that patent infringement litigation pertaining to Teva's generic version of sanofi-aventis and Debiopharm's Eloxatin (oxaliplatin” View full resource at medicalnewstoday.com
Most Recently Shared on April 5, 2010 at 4:08 pm By:
MNT Med Malpractice Health News
Teva Settles Generic Eloxatin Litigation http://mnt.to/3zPD #medicalmalpractice
Sanofi Settles Eloxatin Patent Lawsuit - WSJ.com
online.wsj.com — “Sanofi-Aventis said it settled a U.S. patent lawsuit with four generic-drug makers over their versions of its cancer treatment Eloxatin.” View full resource at online.wsj.com
Most Recently Shared on April 2, 2010 at 4:05 am By:
Generic Sanofi Drugs Are Delayed http://on.wsj.com/a1134Q
Therapeutics Daily
therapeuticsdaily.com — “Therapeutics Daily” View full resource at therapeuticsdaily.com
Most Recently Shared on June 19, 2009 at 8:12 pm By:
PharmaLive Pharma and Health News
Court Authorizes Generic Version of Sanofi-Aventis' Eloxatin -- http://tinyurl.com/lxxv6g
APP, Fresenius Kabi and sanofi-aventis sign license and settlement agreements
news-medical.net — “Fresenius Kabi Pharmaceuticals Holding, Inc.,, the parent company of APP Pharmaceuticals, Inc., announced today that APP and other Fresenius Kabi companies have entered into license and settlement agreements with sanofi-aventis covering patents that apply to Eloxatin® (oxaliplatin injection and oxaliplatin for injection).” View full resource at news-medical.net
Most Recently Shared on April 2, 2010 at 6:26 am By:
News-Medical.Net Health News and Oncology
Oncology News: APP, Fresenius Kabi and sanofi-aventis sign license and settlement agreements: Fresenius Kabi Pharm... http://bit.ly/cXbIMw
NCI Cancer Bulletin for February 23, 2010 - National Cancer Institute
cancer.gov — “NCI's biweekly online newsletter provides useful, timely information about cancer research to the cancer community.” View full resource at cancer.gov
Most Recently Shared on February 24, 2010 at 1:21 pm By:
NCI Cancer Bulletin Health News
More on chemotherapy-induced peripheral neuropathy in this issue's featured clinical trial http://bit.ly/9OFWOv
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MNT Med Malpractice
The latest medical litigation and medical malpractice news published daily. Articles from research centers, universities and prestigious journals.
-
WSJ Health
Health news coverage from the Wall Street Journal
-
PharmaLive
Advertisement
